Completed
Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer
NCT03759587
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- Aichi Cancer Center Hospital Nagoya, Aichi-ken, Japan
- Hirosaki University Hospital Hirosaki, Aomori, Japan
- Shikoku Cancer Center Matsuyama, Ehime, Japan
- Ehime University Hospital Tōon, Ehime, Japan